Bay Bioanalytical Laboratory Provides Biomarker Support to Successful…
BBL, recently acquired by Pacific BioLabs, contributed to a successful orphan drug Phase 3 trial of BioMarin's GALNS for Morquio Syndrome.
(PRWeb January 28, 2013)
Read the full story at http://www.prweb.com/releases/2013/1/prweb10364528.htmClick here for reuse options!
Copyright 2013 Biotechblog
Comments are closed.